Federal Register / Vol. 80, No. 16 / Monday, January 26, 2015 / Notices 3983 

substances is consistent with the public 

interest and with United States 

obligations under international treaties, 

conventions, or protocols in effect on 

May 1, 1971. The DEA investigated the 

company’s maintenance of effective 

controls against diversion by inspecting 

and testing the company’s physical 

security systems, verifying the 

company’s compliance with state and 

local laws, and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed: 

Controlled substance Schedule 

Cocaine (9041) ............................. II 

Oxycodone (9143) ........................ II 

Hydrocodone (9193) ..................... II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

The company plans to manufacture 

the listed controlled substances as bulk 

reagents for use in drug abuse testing. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01305 Filed 1–23–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Euticals, Inc. 

ACTION: Notice of registration. 

SUMMARY: Euticals, Inc. applied to be 

registered as a manufacturer of certain 

basic classes of controlled substances. 

The DEA grants Euticals, Inc. 

registration as a manufacturer of those 

controlled substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated June 10, 2014, and published in 

the Federal Register on June 17, 2014, 

79 FR 34554, Euticals, Inc., 2460 W. 

Bennett Street, Springfield, Missouri 

65807–1229, applied to be registered as 

a manufacturer of certain basic classes 

of controlled substances. No comments 

or objections were submitted to this 

notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Euticals, Inc. to manufacture the basic 

classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. The 

DEA investigated the company’s 

maintenance of effective controls 

against diversion by inspecting and 

testing the company’s physical security 

systems, verifying the company’s 

compliance with state and local laws, 

and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed: 

Controlled Substance Schedule 

Methadone (9250) ........................ II 

Oripavine (9330) ........................... II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution and sale to its 

customers. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01307 Filed 1–23–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Stepan 

Company 

ACTION: Notice of registration. 

SUMMARY: Stepan Company applied to 

be registered as a manufacturer of 

certain basic classes of controlled 

substances. The DEA grants Stepan 

Company registration as a manufacturer 

of those controlled substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated May 28, 2014, and published in 

the Federal Register on June 4, 2014, 79 

FR 32320, Stepan Company, Natural 

Products Dept., 100 W. Hunter Avenue, 

Maywood, New Jersey 07607, applied to 

be registered as a manufacturer of 

certain basic classes of controlled 

substances. No comments or objections 

were submitted to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Stepan Company to manufacture the 

basic classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. The 

DEA investigated the company’s 

maintenance of effective controls 

against diversion by inspecting and 

testing the company’s physical security 

systems, verifying the company’s 

compliance with state and local laws, 

and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed: 

Controlled substance Schedule 

Cocaine (9041) ............................. II 

Ecgonine (9180) ........................... II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01290 Filed 1–23–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Ampac Fine 

Chemicals, LLC 

ACTION: Notice of registration. 

SUMMARY: AMPAC Fine Chemicals, LLC 

applied to be registered as a 

manufacturer of certain basic classes of 

controlled substances. The DEA grants 

AMPAC Fine Chemicals, LLC 

registration as a manufacturer of the 

controlled substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated June 10, 2014, and published in 

the Federal Register on June 17, 2014, 

79 FR 34553, AMPAC Fine Chemicals 

LLC, Highway 50 and Hazel Avenue, 

Building 05001, Rancho Cordova, 

California 95670, applied to be 

registered as a manufacturer of certain 

basic classes of controlled substances. 

No comments or objections were 

submitted to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

AMPAC Fine Chemicals, LLC to 

manufacture the basic classes of 

controlled substances is consistent with 


emcdonald on DSK67QTVN1PROD with NOTICES